story of the week
Efficacy and Safety of Giredestrant Therapy in Patients With Previously Treated ER+, HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study
J. Clin. Oncol 2024 Mar 27;[EPub Ahead of Print], M Martín, E Lim, M Chavez-MacGregor, A Bardia, J Wu, Q Zhang, Z Nowecki, FM Cruz, R Safin, SB Kim, C Schem, AJ Montero, S Khan, R Bandyopadhyay, HM Moore, M Shivhare, M Patre, J Martinalbo, L Roncoroni, PD Pérez-Moreno, J SohnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.